Neo Ivy Capital Management’s Labcorp LH Stock Holding History

Neo Ivy Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,572	Closed	-$1.2M	–	469
2025 Q2	$1.2M	Buy	4,572 +3,634	+387%	+$885K	0.38%	93
2025 Q1	$218K	Buy	+938	New	+$228K	0.07%	221
2024 Q4	–	Sell	-1,534	Closed	-$342K	–	344
2024 Q3	$342K	Buy	+1,534	New	+$337K	0.11%	195
2023 Q4	–	Sell	-4,760	Closed	-$957K	–	382
2023 Q3	$957K	Buy	+4,760	New	+$1M	0.42%	91
2022 Q4	$1.2M	Buy	5,943 +5,834	+5,352%	+$1.14M	0.81%	18
2022 Q3	$19K	Buy	+109	New	+$22.3K	0.05%	299
2021 Q1	–	Sell	-1,151	Closed	-$201K	–	564
2020 Q4	$201K	Buy	+1,151	New	+$199K	0.22%	162
2020 Q2	–	Sell	-1,470	Closed	-$160K	–	532
2020 Q1	$160K	Buy	1,470 +1,121	+321%	+$162K	0.26%	152
2019 Q4	$51K	Buy	+349	New	+$50.4K	0.06%	204

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Neo Ivy Capital Management's LH Position: Q3 2025 in Review

Neo Ivy Capital Management sold out of Labcorp (LH) in Q3 2025, closing a stake of 4,572 shares — an estimated $1.2M sold.

Neo Ivy Capital Management first reported a position in LH in Q4 2019 and held it in 9 quarters. The position peaked at $1.2M in Q4 2022. 1,011 funds tracked by Wall St. Rank hold LH as of Q3 2025.

Neo Ivy Capital Management reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 4,572 Labcorp shares in Q3 2025, an estimated $1.2M.
Neo Ivy Capital Management first reported a position in Labcorp in Q4 2019 and held it in 9 quarters.
Neo Ivy Capital Management's Labcorp position peaked at $1.2M in Q4 2022.
1,011 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Neo Ivy Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.